Month: August 2022

Total number of shares and voting rights in Zealand Pharma at August 31, 2022

Total number of shares and voting rights in Zealand Pharma at August 31, 2022

Company announcement – No. 37 / 2022 Total number of shares and voting rights in Zealand Pharma at August 31, 2022 Copenhagen, DK and Boston, MA, August 31, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital. In Company announcement No. 35/2022 from August 18, 2022, Zealand announced an increase in share capital relating to exercise of employee warrants. Following this announcement, the table below lists the total number of shares and voting rights in Zealand up to and including...

Continue reading

Montauk Renewables, Inc. Announces Second Apex RNG Facility

Montauk Renewables, Inc. Announces Second Apex RNG Facility

PITTSBURGH, Aug. 31, 2022 (GLOBE NEWSWIRE) — Montauk Renewables, Inc. (NASDAQ: MNTK) (the “Company”) announces the planned construction of a second renewable natural gas (“RNG”) processing facility at its Apex landfill gas project in Amsterdam, Ohio (the “Project”). The planned Project is being driven by projections in biogas feedstock availability from the host landfill over the next 12 to 18 months. The Company is targeting an approximate 40% increase in RNG processing capacity with the addition of the second facility. It is expected to add up to 2,100 MMBtu per day production capacity and expand the infrastructure for the conversion of LFG to RNG. The Project is expected to be completed in 2024, based on currently forecasted biogas feedstock volumes that are anticipated to be available from the host landfill at the time of commissioning. “Montauk...

Continue reading

LeMaitre to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

LeMaitre to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

BURLINGTON, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14, 2022, at 4:40 PM ET at the Sheraton New York Hotel, New York. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com. CONTACT: Contact: Sandra Millar LeMaitre Vascular, Inc. +1-781-425-1686 smillar@lemaitre.com

Continue reading

Press Release: XenpozymeTM (olipudase alfa-rpcp) approved by FDA as first disease-specific treatment for ASMD (non-CNS manifestations)

Press Release: XenpozymeTM (olipudase alfa-rpcp) approved by FDA as first disease-specific treatment for ASMD (non-CNS manifestations)

XenpozymeTM (olipudase alfa-rpcp) approved by FDA as first disease-specific treatment for ASMD (non-CNS manifestations)   Paris, August 31, 2022. The U.S. Food and Drug Administration (FDA) has approved XenpozymeTM (olipudase alfa-rpcp) for the treatment of non-central nervous system (non-CNS) manifestations of acid sphingomyelinase deficiency (ASMD) in adult and pediatric patients. Xenpozyme is the first therapy indicated specifically for the treatment of ASMD, and is currently the only approved treatment for this disease. Bill SiboldExecutive Vice President, Head, Specialty Care at Sanofi “Sanofi teams have been dedicated to bringing hope to patients living with ASMD and their families. This is a devastating and extremely rare disease that affects both children and adults. The approval of Xenpozyme represents the culmination of bold...

Continue reading

<div>Proactive news headlines including Bed Bath & Beyond, SpaceX, American Resources, Guardforce AI, Mindset Pharma, Willow Biosciences and Kontrol Technologies</div>

Proactive news headlines including Bed Bath & Beyond, SpaceX, American Resources, Guardforce AI, Mindset Pharma, Willow Biosciences and Kontrol Technologies

New York , Aug. 31, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Bed Bath & Beyond plunges as cash-strapped retailer announces raft of measures, including store closures, job cuts and a stock offering click here SpaceX partners with Royal Caribbean to provide high-speed internet click here Animoca Brands and Temasek join forces on latest blockchain-based funding round click here Stifel GMP upbeat on Mongolia-focused Steppe Gold following ATO Phase 2 expansion plan update click here Todos Medical inks lease deal on botanical supplement manufacturing facility in Texas to produce Tollovid click here Bloom Health Partners closes in on full year revenue target with strong fiscal 3Q results click here Aftermath...

Continue reading

Nokia Corporation: Repurchase of own shares on 31.08.2022

Nokia Corporation: Repurchase of own shares on 31.08.2022

Nokia CorporationStock Exchange Release31 August 2022 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 31.08.2022 Espoo, Finland – On 31 August 2022 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code) Number of shares Weighted average price / share, EUR* XHEL 236,366 4.94 CEUX 3,617 4.95 AQEU 3,459 4.95 TQEX 3,058 4.95 Total 246,500 4.94 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU)...

Continue reading

Sword Group: Availability of the H1 2022 Financial Report

Sword Group: Availability of the H1 2022 Financial Report

Financial Announcement Windhof – August, 31st 2022 Sword Group – Availability of the 2022 Interim Financial Report According to the current regulations, Sword Group announces that its 2022 Interim Financial Report has been made available to the public. It was sent to the Commission de Surveillance du Secteur Financier (CSSF) and was also filed with the Luxembourg Stock Exchange. It can be viewed and downloaded on the website of the company: 2022 INTERIM FINANCIAL REPORT Agenda07/09/22Meeting to present the Half-Yearly Results for 2022 at 10:00am (CET), Paris REGISTRATION25/10/22Publication of Q3 2022 Results About Sword GroupSword has 2,500+ IT/Digital & Software specialists present over 5 continents to accompany you in the growth of your organisation in the digital age.As a leader in technological and digital transformation,...

Continue reading

Asure Expands and Streamlines 401(k) Plan Options for Small Employers with 80+ Provider Integrations and New Partnership

Asure Expands and Streamlines 401(k) Plan Options for Small Employers with 80+ Provider Integrations and New Partnership

Leading payroll provider for small and mid-sized businesses makes it easy for organizations of all sizes to offer competitive retirement plans with API integrations AUSTIN, Texas, Aug. 31, 2022 (GLOBE NEWSWIRE) — Asure Software, Inc., (Nasdaq: ASUR), a leading provider of cloud-based Human Capital Management (“HCM”) software solutions, today announced its payroll systems now feature direct integration with more than 80 401(k) providers. The time and expense required to maintain traditional options for providing employer-sponsored 401(k) plans have been a longtime barrier to entry for smaller employers. Asure is actively removing that barrier by making 401(k) plan delivery easier and more accessible for organizations with limited resources. Asure’s established integrations enable employers to sync their Asure payroll system and...

Continue reading

McEwen Copper Completes Oversubscribed US$81.85 Million Offering Including a $25 Million Investment by Nuton, a Rio Tinto Venture

McEwen Copper Completes Oversubscribed US$81.85 Million Offering Including a $25 Million Investment by Nuton, a Rio Tinto Venture

TORONTO, Aug. 31, 2022 (GLOBE NEWSWIRE) — McEwen Copper Inc., a subsidiary of McEwen Mining Inc. (NYSE: MUX) (TSX: MUX), is pleased to announce the closing of the third and final tranche of the previously announced private placement offering (the “Offering”) of up to 8,000,000 common shares of McEwen Copper Inc. priced at US$10.00 per common share. The third tranche is comprised of a $25 million investment by Rio Tinto’s copper leaching technology venture, Nuton (“Nuton” or the “Investor”), and $1.85 million from other investors. The total Offering has been increased to 8,185,000 common shares, with the amounts raised in the three tranches of the private placement totalling $81.85 million. McEwen Copper is well-funded to advance its Los Azules Project, located in the mining friendly province of San Juan, Argentina. The next milestones...

Continue reading

Sword Group: H1 2022 Report of the Liquidity Agreement

Sword Group: H1 2022 Report of the Liquidity Agreement

Liquidity Contract Windhof – August, 31st 2022 Sword Group – H1 Report of the Liquidity Agreement contracted with ODDO BHF from 01/01/2022 au 30/06/2022 Under the liquidity contract awarded by Sword Group to ODDO BHF, as of 30/06/2022, the following resources appeared on the account of liquidity: 13,820 shares €296,701 – Number of transactions executed during the semester at purchase: 1,271 – Number of transactions executed during the semester on sale: 984 – Volume exchanged over the semester upon purchase: 49,859 shares for an amount of €2,098,424 – Volume exchanged over the semester for sale: 39,843 shares for an amount of €1,769,407 As a reminder, during the last balance sheet of 31/12/2021, the following resources appeared in the liquidity account: 3,804 shares €625,718 The implementation of the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.